Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-inflammatory activity of GSK315234 in synovial tissue in rheumatoid arthritis
2009-012055-19Phase 2Terminated
- Sponsor
- GSK
- Start
- Feb 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in rheumatoid arthritis (RA) comparing GSK315234 arm with Placebo arm (2 arms). Primary endpoint: Synovial sub-lining CD68+ macrophage infiltration. Started Feb 2010; status: terminated.
02
Drugs
GSK315234
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2009-012055-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012055-19.